The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.

High-volume centres achieve excellent long-term survival and low reoperation rates in mitral valve repair—key findings ...

Nixon also shared what she's learned about leadership since becoming CEO of structural heart surgical robotics startup ...